GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » PEG Ratio

Shenzhen YHLO Biotech Co (SHSE:688575) PEG Ratio : 0.54 (As of Apr. 12, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Shenzhen YHLO Biotech Co's PE Ratio without NRI is 27.01. Shenzhen YHLO Biotech Co's 5-Year EBITDA growth rate is 50.30%. Therefore, Shenzhen YHLO Biotech Co's PEG Ratio for today is 0.54.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Shenzhen YHLO Biotech Co's PEG Ratio or its related term are showing as below:

SHSE:688575' s PEG Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.55   Max: 0.67
Current: 0.54


During the past 7 years, Shenzhen YHLO Biotech Co's highest PEG Ratio was 0.67. The lowest was 0.11. And the median was 0.55.


SHSE:688575's PEG Ratio is ranked better than
88.11% of 244 companies
in the Medical Devices & Instruments industry
Industry Median: 2.015 vs SHSE:688575: 0.54

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Shenzhen YHLO Biotech Co PEG Ratio Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co PEG Ratio Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - - 0.13 1.17

Shenzhen YHLO Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.17 - - -

Competitive Comparison of Shenzhen YHLO Biotech Co's PEG Ratio

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's PEG Ratio falls into.


;
;

Shenzhen YHLO Biotech Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Shenzhen YHLO Biotech Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=27.005347593583/50.30
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Shenzhen YHLO Biotech Co  (SHSE:688575) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Shenzhen YHLO Biotech Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Song Yong Bo Directors, senior managers
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines